Cynosure Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $813K | Buy |
5,918
+2,016
| +52% | +$277K | 0.09% | 115 |
|
|
2025
Q1 | $704K | Buy |
3,902
+272
| +7% | +$49K | 0.1% | 105 |
|
|
2024
Q4 | $569K | Sell |
3,630
-359
| -9% | -$56.2K | 0.09% | 123 |
|
|
2024
Q3 | $726K | Sell |
3,989
-335
| -8% | -$61K | 0.11% | 116 |
|
|
2024
Q2 | $794K | Buy |
4,324
+557
| +15% | +$102K | 0.13% | 99 |
|
|
2024
Q1 | $670K | Buy |
+3,767
| New | +$670K | 0.12% | 99 |
|